INCB-52793-101: A Phase 1a/1b, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies - Regional Cancer Care Associates LLC

Clinical Trials

INCB-52793-101: A Phase 1a/1b, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies

Type of Cancer
Multiple Myeloma
Locations
Hackensack
Sponsor
Incyte
Protocol Number
INCB 52793-101
Cancer Diagnosis
To Learn More Call
201-510-0910